April 12, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jordan Nimitz
| Re: | Humanigen, Inc. Registration Statement on Form S-3 |
(File No. 333-263132)
Acceleration Request
Requested Date: April 14, 2022
Requested Time: 4:05 P.M. Eastern Daylight Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Humanigen, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Polsinelli PC, by calling Kevin L. Vold at (202) 626-8357.
| Sincerely, | |
| HUMANIGEN, INC. | |
| /s/ Cameron Durrant | |
| Cameron Durrant, M.D., MBA | |
| Chairman of the Board and Chief Executive Officer |
Enclosures
cc: Kevin L. Vold, Polsinelli PC